Romfirst 1000mg/500mg Injection
Marketer
Panzin Healthcare Private Limited
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Romfirst 1000mg/500mg Injection
Combifirst 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is crucial. Complete the full treatment regimen, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your doctor. Seek urgent medical attention for allergic reactions (e.g., rashes, pruritus, edema, dyspnea). Inform your physician about all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order lab tests to monitor the medication's impact.
Uses of Romfirst 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Romfirst 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Romfirst 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Romfirst 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Romfirst 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Romfirst 1000mg/500mg Injection, offer a dual antibiotic approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Romfirst 1000mg/500mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Romfirst, at a dosage of 1000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Romfirst 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Romfirst 1000mg/500mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Romfirst 1000mg/500mg Injection use in patients with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Romfirst 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Romfirst 1000mg/500mg Injection are not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Romfirst 1000mg/500mg Injection :
Should you forget a scheduled Romfirst 1000mg/500mg Injection, seek your physician's advice.
Facts to Know About Romfirst 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently